Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-06-15 00:00:00 ET · period of report 2022-06-13 · accession 0001562180-22-005117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-15 | 2022-06-13 | SNDX | Goldan Keith A. | CFO | A - Grant | $0.00 | +3,205 | 3,205 | New | $0 |
| D | 2022-06-15 | 2022-06-13 | SNDX | Goldan Keith A. | CFO | A - Grant | $15.60 | +230.0K | 230.0K | New | +$3.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-13 | A | A | 3,205 | $0.00 | 3,205 | D | — | — | (F1) Award of Restricted Stock Units that vest 50% of the shares on June 13, 2023 and the remaining 50% of the shares on June 13, 2024. |
| 2 | Derivative | Stock Options (Right to buy) | 2022-06-13 | A | A | 230,000 | $15.60 | 230,000 | D | $15.60 · — to 2032-06-13 | 230,000 Common Stock | (F2) Twenty five percent (25%) of the total number of shares underlying the option shall vest on June 13, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. |